EMA flow cytometry: what to know

EMA, or epithelial membrane antigen, is a marker found on some cell surfaces. In [Flow Cytometry](/technology/flow-cytometry/), cells from blood, bone marrow, or another sample are labelled with antibodies and passed through a laser-based analyser. The pattern of markers helps a laboratory identify cell groups and compare their features. EMA findings are interpreted with other markers, cell appearance, blood counts, symptoms, and the suspected diagnosis. A positive or negative EMA result by itself does not prove or exclude cancer.

Ask what sample was tested and why EMA was included in the panel. Usually, preparation depends on the sample rather than the marker; your clinic will explain any instructions. If the sample came from marrow, a [Bone Marrow Biopsy](/treatments/diagnostics-and-staging/bone-marrow-biopsy/) may have been used to obtain it. The final interpretation may take time because several laboratory findings are reviewed together.

The test itself is not an emergency. Seek prompt advice after a blood draw or biopsy for persistent bleeding, increasing redness, swelling, drainage, fever, or worsening pain. Contact the clinical team urgently for severe breathlessness, fainting, confusion, or rapidly worsening weakness while awaiting results.

Ask which cell population showed EMA, what the complete marker pattern suggests, whether more testing is needed, and when the report will be reviewed. Ask how the result fits your blood counts, symptoms, imaging, or biopsy findings.